30 participants
Sintilimab in Combination With Bevacizumab and Temozolomide in Recurrent Glioblastoma (GBM) Patients
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2024-06-05
- Start Date:
- 2023-05-01
- Completion:
- 2024-12-30
Conditions
- Recurrent Glioblastoma
Interventions
- DRUG
No Results Yet